Holen Sie sich die Stockscreener-App
4.94
1.23%
0.06
Handel nachbörslich:
4.82
-0.12
-2.43%
Schlusskurs vom Vortag:
$4.88
Offen:
$4.75
24-Stunden-Volumen:
15,016
Relative Volume:
1.71
Marktkapitalisierung:
$11.06M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+4.00%
1M Leistung:
+0.00%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$4.75
$5.00
1-Wochen-Bereich:
$4.59
$5.15
52-Wochen-Spanne:
$4.0408
$5.75
Bio Green Med Solution Inc Stock (BGMS) Company Profile
Firmenname
Bio Green Med Solution Inc
Sektor
Branche
Telefon
908-517-7330
Adresse
200 CONNELL DRIVE, BERKELEY HEIGHTS
Vergleichen Sie BGMS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BGMS
Bio Green Med Solution Inc
|
4.94 | 14.34M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Bio Green Med Solution Inc Stock (BGMS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-07-18 | Fortgesetzt | Oppenheimer | Outperform |
| 2020-04-27 | Fortgesetzt | ROTH Capital | Buy |
| 2018-09-07 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2015-10-16 | Eingeleitet | H.C. Wainwright | Buy |
| 2010-02-04 | Eingeleitet | Roth Capital | Buy |
| 2009-10-28 | Eingeleitet | Merriman | Buy |
| 2008-08-12 | Eingeleitet | Piper Jaffray | Buy |
| 2008-03-12 | Bestätigt | Cantor Fitzgerald | Buy |
| 2008-03-12 | Bestätigt | Collins Stewart | Buy |
| 2008-03-12 | Bestätigt | Needham & Co | Buy |
| 2007-11-27 | Bestätigt | Cantor Fitzgerald | Buy |
| 2007-08-10 | Bestätigt | Cantor Fitzgerald | Buy |
| 2007-06-04 | Bestätigt | Needham & Co | Buy |
| 2007-04-23 | Eingeleitet | Lazard Capital | Buy |
| 2007-04-10 | Eingeleitet | Cantor Fitzgerald | Buy |
Alle ansehen
Bio Green Med Solution Inc Aktie (BGMS) Neueste Nachrichten
Biodexa Pharmaceuticals Stock Price, Quotes and Forecasts | NASDAQ:BDRX - Benzinga
Bio Green Med Solution Appoints New Independent Director - TipRanks
Cyclacel Pharmaceuticals: Recent Acquisition Completed - MSN
Bio Green Med Solution Faces Nasdaq Delisting Notice - TipRanks
BlackRock® Canada Announces Product Changes - The Manila Times
Inception Growth Acquisition Limited Announces Additional Contribution to Trust Account to Extend Business Combination Period - The Manila Times
Bio Green Med Solution announces closing of strategic acquisition of Fitters Sdn. Bhd. - MarketScreener
Bio Green Med Solution, Inc. Completes Acquisition of Fitters Sdn. Bhd. to Diversify Business Portfolio - Quiver Quantitative
Major Shareholder Cashes Out Big on Cyclacel Pharmaceuticals! - TipRanks
Cyclacel Pharmaceuticals Approves Key Shareholder Proposals - TipRanks
Cyclacel Pharmaceuticals shareholders approve share issuance and name change - Investing.com
Cyclacel Pharmaceuticals : Initial Statement of Beneficial Ownership (Form 3) - MarketScreener
Big Moves And Bigger Questions For Biotech And Tech Stocks - Finimize
Cyclacel Pharmaceuticals to Implement 1-for-15 Reverse Stock Split; Shares Fall - MarketScreener
Cyclacel Pharmaceuticals, Inc. announced that it has received $3 million in funding - MarketScreener
CYCLACEL PHARMACEUTICALS REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT - MarketScreener
Fitters swaps fire safety arm for 19.99% stake in Nasdaq biotech firm - The Malaysian Reserve
Wacker Buys Manufacturing Assets and Know-how of Bio Med Sciences - CHEManager
Cyclacel Pharmaceuticals, Inc. Announces Chief Executive Officer Changes - MarketScreener
Cyclacel Pharmaceuticals Announces That Nasdaq Granted an Extension to Regain Compliance With the Equity Standard Rule - MarketScreener
Roth MKM Downgrades Cyclacel Pharmaceuticals(CYCC.US) to Hold Rating - 富途牛牛
Cyclacel Pharmaceuticals Confirms It Has Filed an Appeal to Nasdaq Staff Delisting Letter - MarketScreener
WACKER Positions itself as Solution Provider for Silicone-Coated Healthcare Products with New Acquisition - PR Newswire
Cyclacel Pharmaceuticals to Release First Quarter 2024 Financial Results - MarketScreener
Cyclacel Pharmaceuticals to Participate in 2024 BIO CEO and Investor Conference - MarketScreener
Cyclacel Pharmaceuticals Announces the Appointment of Brian Schwartz, M.D. as Chief Medical Officer - MarketScreener
Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business Update - MarketScreener
Cyclacel Pharmaceuticals Reports First Quarter Financial Results and Provides Business Update - MarketScreener
Cyclacel Pharmaceuticals Announces Receipt of $4.7 Million R&D Tax Credit - MarketScreener
Alaunos Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:TCRT - Benzinga
Waste biorefinery towards a sustainable circular bioeconomy: a solution to global issues - Biotechnology for Biofuels and Bioproducts
Cyclacel Pharmaceuticals Announces Management Changes - MarketScreener
Psyence Biomedical Stock Price, Quotes and Forecasts | NASDAQ:PBM - Benzinga
Cyclacel Pharmaceuticals Announces at-the-market $7 Million Strategic Investment by Fundamental Investor Acorn Bioventures - MarketScreener
Cyclacel Pharmaceuticals to Present at the Noble Capital Markets Investor Conference - MarketScreener
Finanzdaten der Bio Green Med Solution Inc-Aktie (BGMS)
Es liegen keine Finanzdaten für Bio Green Med Solution Inc (BGMS) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
2.36%
1.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):